Pfizer Chief Executive Albert Bourla is battling impending expirations for some blockbuster-drug patents and the precipitous ...

Pfizer posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as recently launched ...

Pfizer (NYSE:PFE) chief executive Albert Bourla has signaled a possible shift in tone around US vaccine policy, praising President Donald Trump's latest nominee to lead the Centers for Disease Control ...

Pfizer, Anthropic and longevity scientists position AI as healthcare's core infrastructure, accelerating drug design and care ...

Pfizer Inc. chief executive Albert Bourla praised the Trump administration’s latest pick to lead the Centers for Disease Control and Prevention after vaccine policy was upended in the past year.

Pfizer has been leaning on recently acquired products to offset a looming patent cliff.

Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug development.

By Rocky Swift TOKYO, May 14 (Reuters) - Bain Capital-owned Tanabe Pharma plans to bring up to three new drugs to Japan each year as the former Mitsubishi Chemical unit doubles down on its home market ...

First quarter earnings season is in full swing, with a full slate of semiconductor and consumer companies slated to report ...

As an SAP specialist at GWC, Ajay Bhaktharahalli Nagesh Hemambika supported Qatar’s logistics operations through the Gulf ...

Obesity drug giant Eli Lilly on Thursday reported a monster first quarter, fortifying our conviction to stick with the stock after a period of sluggishness. Revenue in the three months ended in March ...